Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 343101 - 343120 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01XA03) oxaliplatin | Oksaliplatin SUN 5 mg/ml | 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | SunPharmaceutical-Nederland |
| Norway | (L01XC03) trastuzumab | Herceptin 600 mg | 5 ml, Hetteglass, Injeksjonsvæske, oppløsning, 600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RocheRegistrationGmbH |
| Norway | (L01XC03) trastuzumab | Trazimera 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | PfizerEuropeMAEEIG(1) |
| Norway | (L01XC03) trastuzumab | Trazimera 420 mg | 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | PfizerEuropeMAEEIG(1) |
| Norway | (L01XC06) cetuximab | Erbitux 5 mg/ml | 1 x 20 ml, Hetteglass, Infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms; Colorectal Neoplasms | MerckEuropeB.V. |
| Norway | (L01XC06) cetuximab | Erbitux 5 mg/ml | 1 x 100 ml, Hetteglass, Infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms; Colorectal Neoplasms | MerckEuropeB.V. |
| Norway | (L01XC15) obinutuzumab | Gazyvaro 1 000 mg | 1 x 40 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 1 000 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationGmbH |
| Norway | (L01XC15) obinutuzumab | Gazyvaro 1 000 mg | 1 x 40 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 1 000 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | OrifarmAS |
| Norway | (L01XC23) elotuzumab | Empliciti 300 mg | 300 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 300 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG |
| Norway | (L01XC23) elotuzumab | Empliciti 400 mg | 400 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 400 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG |
| Norway | (L01XC26) inotuzumab ozogamicin | Besponsa 1 mg | 1 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 1 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerEuropeMAEEIG(1) |
| Norway | (L01XC31) avelumab | Bavencio 20 mg/ml | 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckEuropeB.V. |
| Norway | (L01XC39) belantamab mafodotin | Blenrep 100 mg | 100 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 100 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | GlaxoSmithKline(Ireland)Limited |
| Norway | (L01XD03) methyl aminolevulinate | Metvix 160 mg/g | 2 g, Tube, Krem, 160 mg/g , Tube | Retail price with vat |
$0-0 |
$0-0 |
n/a | GaldermaNordicAB |
| Norway | (L01XD04) aminolevulinic acid | Ameluz 78 mg/g | 1 x 2 g, Tube, Gel, 78 mg/g , Tube | Retail price with vat |
$0-0 |
$0-0 |
Keratosis, Actinic; Carcinoma, Basal Cell | BiofronteraBioscienceGmbH |
| Norway | (L01XD04) aminolevulinic acid | Alacare 8 mg | 1 x 4 stk, Dosepose, Medisinert plaster, 8 mg , Dosepose | Retail price with vat |
$0-0 |
$0-0 |
n/a | photonamicGmbH&Co.KG |
| Norway | (L01XE01) imatinib | Glivec 100 mg | 120 stk, Blisterpakning, Kapsel, hard, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NovartisEuropharmLimited(1) |
| Norway | (L01XE01) imatinib | Imatinib Cipla 100 mg | 60 stk, Blisterpakning, Kapsel, hard, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | CiplaEuropeNV |
| Norway | (L01XE01) imatinib | Imatinib Cipla 400 mg | 30 stk, Blisterpakning, Kapsel, hard, 400 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | CiplaEuropeNV |
| Norway | (L01XE01) imatinib | Glivec 100 mg | 60 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NovartisEuropharmLimited(1) |
Pages
